Desmopressin test for ACTH-dependent Cushing syndrome
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies how well a desmopressin stimulation test works to diagnose ACTH-dependent Cushing syndrome. It compares results from people with possible or recurrent Cushing syndrome and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 70 years.
- Able to follow study rules and procedures.
- No known allergy to desmopressin.
- Not pregnant or breastfeeding.
- No uncontrolled high blood pressure or heart conditions.
- No recent use of certain medications that affect cortisol or interfere with the test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to use a medicine called desmopressin with a special type of imaging (PET/CT) to help find cortisol-producing tumors in people with Cushing's syndrome. It may help doctors better locate the problem without needing as much radiation.
This is a study that collects and reviews information about how people with Cushing’s syndrome (including some mild forms and certain “silent” tumors) are diagnosed and treated, and what outcomes they have. It may help researchers understand which treatments work best in different types of the condition.
This study looks at how Cushing’s syndrome affects people before treatment and what changes after treatment. It may help researchers understand what to expect and improve care for adults with newly diagnosed Cushing’s syndrome.
This study tests whether giving DDAVP before a PET scan can help doctors better locate the pituitary problem in people with Cushing disease. It may help confirm where the ACTH-producing tumor is so surgery can be planned more accurately.
This trial tests several special imaging scans to help doctors locate the source of hormone overproduction in ectopic Cushing syndrome. It may help confirm where the problem is so treatment can be better targeted.
This study checks long-term health in people who were treated successfully for Cushing disease when they were under 21. It also collects information from family members to study genetic links to pituitary tumors.
Hear when a new Cushing Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.